162 related articles for article (PubMed ID: 20039426)
1. Statin treatment of rheumatoid arthritis: comment on the editorial by Ridker and Solomon.
Peters MJ; Nurmohamed MT; Kitas GD; Sattar N
Arthritis Rheum; 2010 Jan; 62(1):302-3. PubMed ID: 20039426
[No Abstract] [Full Text] [Related]
2. Should patients with rheumatoid arthritis receive statin therapy?
Ridker PM; Solomon DH
Arthritis Rheum; 2009 May; 60(5):1205-9. PubMed ID: 19404973
[No Abstract] [Full Text] [Related]
3. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
Couzin J
Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
[No Abstract] [Full Text] [Related]
4. [Statin cuts cardiovascular risk in half].
Einecke D
MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
[No Abstract] [Full Text] [Related]
5. High-sensitivity C-reactive protein in every chart? The use of biomarkers in individual patients.
Ben-Yehuda O
J Am Coll Cardiol; 2007 May; 49(21):2139-41. PubMed ID: 17531664
[TBL] [Abstract][Full Text] [Related]
6. JUPITER study highlights C-reactive protein as a cardiac risk factor.
Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
[No Abstract] [Full Text] [Related]
7. [CRP level as risk marker of cardiovascular disease?].
Thelle DS; Arnesen E
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):512-4. PubMed ID: 20224622
[No Abstract] [Full Text] [Related]
8. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
Stewart RA
Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
Ridker PM
J Am Coll Cardiol; 2007 May; 49(21):2129-38. PubMed ID: 17531663
[TBL] [Abstract][Full Text] [Related]
10. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
11. A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease.
Packard C
Atheroscler Suppl; 2006 Apr; 7(1):21-9. PubMed ID: 16504600
[TBL] [Abstract][Full Text] [Related]
12. [The JUPITER study].
Gaspardone A; Maseri A
G Ital Cardiol (Rome); 2009 May; 10(5):267-70. PubMed ID: 19537439
[No Abstract] [Full Text] [Related]
13. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
Fabbri G; Maggioni AP
Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin and cardiovascular disease: did the strongest statin hold the initial promises?
Efthimiadis A
Angiology; 2008; 59(2 Suppl):62S-4S. PubMed ID: 18628276
[TBL] [Abstract][Full Text] [Related]
15. More evidence support benefits of statins for low-risk patients. Study adds more fuel to the debate on whether to prescribe statins for patients with low levels of C-reactive protein and LDL cholesterol.
Duke Med Health News; 2011 May; 17(5):6. PubMed ID: 21766532
[No Abstract] [Full Text] [Related]
16. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
Toth PP; Davidson MH
J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
[No Abstract] [Full Text] [Related]
17. Are statin effects mediated through, or in spite of, their cholesterol-lowering action?
Mascitelli L; Pezzetta F; Goldstein MR
Angiology; 2009; 60(2):262-3. PubMed ID: 19141486
[No Abstract] [Full Text] [Related]
18. C-reactive protein and cardiovascular risk: more fuel to the fire.
Boekholdt SM; Kastelein JJ
Lancet; 2010 Jan; 375(9709):95-6. PubMed ID: 20031200
[No Abstract] [Full Text] [Related]
19. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
[No Abstract] [Full Text] [Related]
20. Statin effects in CKD: is there a "point of no return"?
Wanner C
Am J Kidney Dis; 2009 May; 53(5):723-5. PubMed ID: 19393469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
